Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105152946B reveals ionic liquid catalysis for o-aminobenzaldehyde. High yield, mild conditions, supply chain stability. Ideal for pharmaceutical intermediate manufacturing.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Novel Mo/Cu co-catalyzed method for 3-CF3-1,2,4-triazoles. High yield, mild conditions, scalable API intermediate production for global supply chains.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.
Patent CN113620795B details a novel Rh-catalyzed route to benzocycloheptenones. Discover cost-effective API intermediate manufacturing with high scalability.
Patent CN116063223A reveals a metal-free TfOH catalyzed route for 10-perfluoroalkyl-5,10-dihydroindeno[1,2-b]indoles, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Novel FeCl3-catalyzed route for quinazolinones offers high yields and cost efficiency for pharmaceutical manufacturing supply chains.
Novel Ru-catalyzed C-H activation method for benzindole derivatives offers mild conditions and green solvents, ensuring reliable supply chain and cost efficiency.
Novel synthesis route avoids explosive diazo compounds, offering high purity and scalable production for pharmaceutical intermediates globally.
Patent CN113735867B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN111468191A details a safe, scalable phosphorus ylide route for Grubbs catalysts, offering cost reduction and supply chain stability for fine chemical manufacturing.
Patent CN114308121A discloses novel phosphine oxide catalysts enabling catalytic Mitsunobu reactions. Achieve high stereoselectivity, reduced waste, and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN117820316B reveals efficient chiral phosphoric acid catalysis for high-purity antitumor intermediates, offering significant cost reduction and supply reliability.
Patent CN113912618A reveals a novel base-catalyzed route for Dioxa[5]helicene. Achieve high purity and cost reduction in optoelectronic material manufacturing without transition metals.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Novel chiral phosphoric acid catalysis enables high-purity pharmaceutical intermediates with scalable production capabilities and significant cost reduction for global supply chains demanding reliable API intermediate sources.
Patent CN110467555A reveals chiral phosphoric acid catalysis for high-purity axial chiral arylindole compounds, offering cost reduction and supply chain reliability.
Patent CN106467481B enables visible-light synthesis of indole ketones without transition metals, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Advanced synthesis of chiral six-membered NHC precursor salts offering enhanced stability and catalytic efficiency for pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN112920173A details a mild chiral phosphoric acid catalyzed synthesis of cytotoxic chroman derivatives, offering high enantioselectivity and scalable API intermediate manufacturing.